# Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

> **NCT00469378** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 46 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** firategrast

## Key facts

- **NCT ID:** NCT00469378
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-05
- **Final completion:** 2010-02
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469378, "Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00469378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*